Metacognitive Training for Negative Symptoms
NCT06127004 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2024-02-06
Summary
There is a clear rationale for developing interventions targeting negative symptoms of schizophrenia as these are a stronger indicator of current and future functioning than positive symptoms and because they respond poorly to medication and existing psychological interventions. This is reflected in the NIMH-MATRICS consensus statement that emphasised that persistent negative symptoms represent an unmet therapeutic need for patients suffering from schizophrenia.
The purpose of this study is to evaluate, in a scientific manner, the intervention developed by Swanson et al. 2021: Metacognitive Training (MCT) Minus. The MCT was adapted to target negative symptoms in psychotic disorders (e.g. schizophrenia, schizoaffective or non-affective functional psychosis) as the original version of the intervention focused exclusively on positive symptoms. The specific aim is to study whether MCT Minus is a promising treatment for the intended population in terms of reductions in negative symptoms, severity of defeatist attitudes, internalised stigma, and depression as well as improvements in reflective ability and overall functioning.
The research will add to existing research by identifying and measuring potential mechanisms of change for negative symptoms (i.e., defeatist attitudes, reflective functioning, stigma and depression). It will also add to the existing evidence base by measuring whether the cognitive biases addressed in MCT lead to changes in the wider conceptualisation of metacognition used elsewhere and whether the promising results seen in the feasibility study of MCT Minus can be replicated in a randomised controlled trial (RCT) with a control group and a blinded assessor. The researchers also hope to replicate the findings of a previous study, where MCT was found to be related to the modulation of default-mode network (DMN) homogeneity in schizophrenia, an area thought to be involved in self- and other-reflectivity.
Conditions
- Negative Symptoms in Schizophrenia
Interventions
- OTHER
-
Metacognitive Training for Negative Symptoms (MCT)
See arm/group descriptions
- OTHER
-
Supportive Counselling
Se arm/group descriptions
Sponsors & Collaborators
-
Uppsala County Council, Sweden
collaborator OTHER_GOV -
Västmanland County Council, Sweden
collaborator OTHER_GOV -
Sormland County Council, Sweden
lead OTHER
Principal Investigators
-
Linda Swanson, Dr · Region Sörmland/ Uppsala University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2030-12-31
- Completion
- 2032-12-31
Countries
- Sweden
More Related Trials
-
Metacognitive Intervention for Individuals With Severe Mental Disorders
NCT05556941 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Metacognitive Training for Schizophrenia - a Study Protocol
NCT03891186 ·Status: COMPLETED ·Phase: NA
-
Effect of 4-session Metacognitive Training in Chinese Adult Outpatients With Schizophrenia Spectrum Disorders and Major Depressive Disorder
NCT03449394 ·Status: COMPLETED ·Phase: NA
-
Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders
NCT06423651 ·Status: RECRUITING ·Phase: NA
-
Cognitive Therapy for Negative Symptoms and Functioning
NCT00350883 ·Status: COMPLETED ·Phase: PHASE2
-
Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms
NCT00757978 ·Status: COMPLETED ·Phase: PHASE4
-
Mobile CBT for Negative Symptoms
NCT03621774 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Motivation Skills Training (MST)
NCT05805397 ·Status: RECRUITING ·Phase: NA
-
Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia
NCT00654706 ·Status: COMPLETED ·Phase: PHASE3
-
Functional Neuroimaging Effects of Cognitive Remediation Training
NCT00481156 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Metacognitive Therapy on Negative Symptoms: a Case Series
NCT03999112 ·Status: UNKNOWN ·Phase: NA
-
Motivational Negative Symptoms in Schizophrenia: Intervention and Biomarkers
NCT02386605 ·Status: COMPLETED ·Phase: NA
-
Personalized Metacognitive Training for Psychosis: A Randomized Controlled Trial
NCT07146802 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Magnetoencephalographic (MEG) Correlates of Negative Symptoms in Patients Suffering From Schizophrenia and Their Influence by Add-on Treatments
NCT00894296 ·Status: UNKNOWN
-
Intervention Targeting Motivational Negative Symptoms
NCT04325100 ·Status: COMPLETED ·Phase: NA
-
Social Cognition and Interaction Training for Improving Social Functioning in People With Schizophrenia
NCT00601224 ·Status: COMPLETED ·Phase: PHASE1
-
Skills Training to Enhance Vocational Outcomes in Veterans With Serious Mental Illness
NCT02663349 ·Status: COMPLETED ·Phase: NA
-
The Study of Minocycline for Negative and Cognitive Symptoms in Schizophrenia
NCT01493622 ·Status: COMPLETED ·Phase: PHASE4
-
Culturally Based Family Therapy for Improving Treatment Outcome for People With Schizophrenia
NCT00356317 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of the Individualized Metacognitive Training (EMC+) in People With Psychosis of Brief Evolution
NCT04429412 ·Status: COMPLETED ·Phase: NA
-
Cognitive Remediation of Schizophrenia in a Community Mental Health Setting
NCT01988714 ·Status: COMPLETED ·Phase: NA
-
Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis
NCT01570972 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Behavioral Activation Treatment for Schizophrenia
NCT05764148 ·Status: UNKNOWN ·Phase: NA
-
High-Definition Transcranial Direct Current Stimulation as a Treatment of Negative Symptoms of Schizophrenia
NCT03602716 ·Status: TERMINATED ·Phase: NA
-
Schizophrenia TreAtment With electRic Transcranial Stimulation
NCT02535676 ·Status: COMPLETED ·Phase: PHASE3